Cite
HARVARD Citation
Weber, J. et al. (n.d.). Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial. Lancet oncology. 17 (7), pp. 943-955. [Online].